The Experimental Cancer Medicine Centre (ECMC) Network is a collaboration of world-leading scientists and clinicians who bring together expertise and techniques to drive the discovery, development and testing of new anti-cancer treatments and biomarkers in early phase studies and trials. The ECMC Network is funded by Cancer Research UK and the health departments of England, Wales, Scotland and Northern Ireland with the overall aim to deliver real benefits for patients.
The foundation of each ECMC is a partnership between the local NHS Trust and the university, bringing together university-based health researchers with hospital-based clinical staff and researchers. The Network works closely with other research infrastructure such as the later phase research networks across all four countries of the UK, Clinical Research Facilities (CRFs), Biomedical Research Units (BRUs), and Biomedical Research Centres (BRCs).
How ECMCS contribute to the cancer research pathway
The ECMC Paediatric Network brings together researchers working in early phase trials in children’s cancers at nine centres across the ECMC Network. These Centres work in conjunction with three other paediatric Phase I/II Centres.
The creation of the Paediatric ECMC Network has increased the international profile of the Centres for early phase trials in children, and increased the number of early phase studies opening and being developed across the Paediatric Network.